Search

Displaying results 21 - 30 of 58 in total
  1. Indication

    Unresectable, advanced metastatic Esophageal squamus cell carcinoma (ESCC)

    go.drugbank.com/conditions/DBCOND0173462
    Drugs: Hyaluronidase (human recombinant) · Nivolumab
  2. Indication

    Unresectable, recurrent Esophageal Squamous Cell Carcinoma (ESCC)

    go.drugbank.com/conditions/DBCOND0145164
    Drugs: Hyaluronidase (human recombinant) · Nivolumab
  3. Indication

    Unresectable Alveolar Soft Part Sarcoma

    go.drugbank.com/conditions/DBCOND0131862
    Drugs: Atezolizumab · Hyaluronidase (human recombinant)
  4. Indication

    Advanced Gastroesophageal Junction Adenocarcinoma

    go.drugbank.com/conditions/DBCOND0120535
    Drugs: Hyaluronidase (human recombinant) · Nivolumab
  5. Indication

    Poor Risk Advanced Renal Cell Cancer

    go.drugbank.com/conditions/DBCOND0145158
    Drugs: Hyaluronidase (human recombinant) · Nivolumab
  6. Indication

    Unresectable Urothelial Carcinoma

    go.drugbank.com/conditions/DBCOND0116739
    Drugs: Hyaluronidase (human recombinant) · Nivolumab
  7. Indication

    Metastatic Esophageal Squamous Cell Carcinoma

    go.drugbank.com/conditions/DBCOND0054799
    Drugs: Hyaluronidase (human recombinant) · Ipilimumab · Nivolumab · Tislelizumab
  8. Indication

    Chronic Inflammatory Demyelinating Polyradiculoneuropathy

    go.drugbank.com/conditions/DBCOND0030996
    Drugs: Efgartigimod alfa · Human immunoglobulin G · Hyaluronidase (human recombinant)
  9. Indication

    Drug Extravasation

    go.drugbank.com/conditions/DBCOND0029080
    Drugs: Dexrazoxane · Hyaluronidase (human recombinant)
  10. Indication

    Unresectable, advanced Esophageal Squamous Cell Carcinoma (ESCC)

    go.drugbank.com/conditions/DBCOND0145163
    Drugs: Hyaluronidase (human recombinant) · Ipilimumab · Nivolumab